1. Kutlutürk K, Otan E, Yağcı MA, Usta S, Aydın C, Ünal B. Thyroid pathologies accompanying primary hyperparathyroidism: a high rate of papillary thyroid microcarcinoma. Ulus Cerrahi Derg. 2014; 30:125–128. PMID:
25931912.
2. Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, et al. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg. 2020; 271:e21–e93. PMID:
32079830.
Article
3. Brito JP, Al Nofal A, Montori VM, Hay ID, Morris JC. The ımpact of subclinical disease and mechanism of detection on the rise in thyroid cancer ıncidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012. Thyroid. 2015; 25:999–1007. PMID:
26103159.
Article
4. Ríos A, Rodríguez JM, Galindo PJ, Montoya M, Tebar FJ, Sola J, et al. Utility of fine-needle aspiration for diagnosis of carcinoma associated with multinodular goitre. Clin Endocrinol (Oxf). 2004; 61:732–737. PMID:
15579188.
Article
5. Balkwill FR, Mantovani A. Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol. 2012; 22:33–40. PMID:
22210179.
Article
6. Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P, et al. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies. Cancer Treat Rev. 2017; 58:1–13. PMID:
28602879.
Article
7. Kiernan CM, Schlegel C, Kavalukas S, Isom C, Peters MF, Solórzano CC. Does concomitant thyroidectomy increase risks of parathyroidectomy? J Surg Res. 2016; 203:34–39. PMID:
27338532.
8. Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, et al. Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg. 2020; 271:399–410. PMID:
32079828.
Article
9. Layfield LJ, Cibas ES, Baloch Z. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium. Cytopathology. 2010; 21:75–85. PMID:
21054821.
Article
10. Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore). 2017; 96:e5886. PMID:
28121932.
Article
11. Emirikçi S, Özçınar B, Öner G, Omarov N, Ağcaoğlu O, Soytaş Y, et al. Thyroid cancer incidence in simultaneous thyroidectomy with parathyroid surgery. Ulus Cerrahi Derg. 2015; 31:214–217. PMID:
26668529.
Article
12. Celik M, Guldiken S, Ayturk S, Bulbul BY, Tastekin E, Can N, et al. Benign and malignant thyroid gland diseases in the patients with primary hyperparathyroidism. Int J Appl Basic Med Res. 2017; 7:117–120. PMID:
28584743.
Article
13. Yazici P, Mihmanli M, Bozdag E, Aygun N, Uludag M. Incidental finding of papillary thyroid carcinoma in the patients with primary hyperparathyroidism. Eurasian J Med. 2015; 47:194–198. PMID:
26644769.
Article
14. Özden S, Saylam B, Daglar G, Yuksek YN, Tez M. Are thyroid nodules an obstacle to minimal invasive parathyroid surgery?: a single-center study from an endemic goiter region. Acta Endocrinol (Buchar). 2019; 15:531–536. PMID:
32377254.
Article
15. Kösem M, Algün E, Kotan C, Harman M, Oztürk M. Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chir Belg. 2004; 104:568–571. PMID:
15571025.
Article
16. Cuhaci N, Ozdemir D, Polat B, Arpacı D, Yıldırım N, Yazgan AK, et al. Concomitant thyroid lesions in patients with primary hyperparathyroidism. Asian J Surg. 2017; 40:338–344. PMID:
26786663.
Article
17. Bentrem DJ, Angelos P, Talamonti MS, Nayar R. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid. 2002; 12:1109–1112. PMID:
12593724.
Article
18. Masatsugu T, Yamashita H, Noguchi S, Nishii R, Koga Y, Watanabe S, et al. Thyroid evaluation in patients with primary hyperparathyroidism. Endocr J. 2005; 52:177–182. PMID:
15863944.
Article
19. Hunter JG. Minimally invasive surgery: the next frontier. World J Surg. 1999; 23:422–424. PMID:
10030867.
Article
20. Sidhu S, Campbell P. Thyroid pathology associated with primary hyperparathyroidism. Aust N Z J Surg. 2000; 70:285–287. PMID:
10779061.
Article
21. Castellano E, Benso P, Attanasio R, Boriano A, Lauro C, Borretta G, et al. Surgical approach to primary hyperparathyroidism in patients with concomitant thyroid diseases: a retrospective single center study. Int J Endocrinol. 2020; 2020:2182539. PMID:
32148486.
Article
22. Krausz Y, Lebensart PD, Klein M, Weininger J, Blachar A, Chisin R, et al. Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J Surg. 2000; 24:1573–1578. PMID:
11193726.
Article
23. Pradhan MC, Young CD, Thomas SM, Stang MT, Kazaure HS, Scheri RP. Outcomes of concurrent parathyroidectomy and thyroidectomy among CESQIP surgeons. Am J Surg. 2022; 224:1190–1196. PMID:
35365294.
Article
24. Roh JL, Kim JM, Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann Surg Oncol. 2011; 18:1312–1318. PMID:
21140230.
Article
25. Li S, Lan X, Gao H, Li Z, Chen L, Wang W, et al. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol. 2017; 143:2455–2468. PMID:
28828692.
Article
26. Lee SY, Lee SI, Min BW, Oh SC. Prognostic implication of systemic inflammatory markers in young patients with resectable colorectal cancer. Ann Surg Treat Res. 2021; 100:25–32. PMID:
33457394.
Article
27. Kim H, Jung HI, Kwon SH, Bae SH, Kim HC, Baek MJ, et al. Preoperative neutrophil-lymphocyte ratio and CEA is associated with poor prognosis in patients with synchronous colorectal cancer liver metastasis. Ann Surg Treat Res. 2019; 96:191–200. PMID:
30941323.
Article
28. Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimitrakopoulos G. The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg. 2013; 205:691–696. PMID:
23388425.
Article
29. Kocer D, Karakukcu C, Karaman H, Gokay F, Bayram F. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders? Asian Pac J Cancer Prev. 2015; 16:3875–3879. PMID:
25987053.
Article
30. Li C, Li J, Li S, Zhao Y, Liu G, Du R, et al. Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2022; 13:984157. PMID:
36060974.
Article
31. Zhang L, Luo H, Wang L, Liu Y, Rui S, Wu Z, et al. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer. J Surg Oncol. 2020; 122:897–905. PMID:
32596828.
Article
32. Figueiredo AA, Esteves S, Moura MM, Marques P, Simões-Pereira J, Leite V. Preoperative serum inflammation-based scores in medullary thyroid cancer. Endocrinol Diabetes Nutr (Engl Ed). 2023; 70:48–55. PMID:
36764748.
Article
33. Ohkuwa K, Sugino K, Katoh R, Nagahama M, Kitagawa W, Matsuzu K, et al. Preoperative inflammatory markers for predicting parathyroid carcinoma. Endocr Connect. 2022; 11:e220062. PMID:
35700222.
Article